Anders Berg Wulff (Anders B Wulff)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Low Density Lipoprotein

Circulating Tumor Cells

Clinical Practice

Top Venues

Current atherosclerosis reports

European heart journal

Arteriosclerosis, thrombosis, and vascular biology

Scandinavian journal of clinical and laboratory investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Anders Berg Wulff, Børge Grønne Nordestgaard, Anne Langsted
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment. Current atherosclerosis reports (2024)
Anders Berg Wulff, Børge Grønne Nordestgaard, Anne Langsted
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment. Current atherosclerosis reports 26 (4) (2024)
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, Børge G Nordestgaard
Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study. Arteriosclerosis, thrombosis, and vascular biology 44 (5) (2024)
Anders Berg Wulff, Børge Grønne Nordestgaard, Anne Langsted
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment. Current atherosclerosis reports 26 (4) (2024)
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, Børge G Nordestgaard
Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study. Arteriosclerosis, thrombosis, and vascular biology 44 (5) (2024)
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, Børge G Nordestgaard
Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study. Arteriosclerosis, thrombosis, and vascular biology (2024)
Anders Berg Wulff, Børge Grønne Nordestgaard, Anne Langsted
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment. Current atherosclerosis reports 26 (4) (2024)
Anders Berg Wulff, Børge Grønne Nordestgaard, Anne Langsted
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment. Current atherosclerosis reports 26 (4) (2024)
Benjamin Nilsson Wadström, Anders Berg Wulff, Kasper Mønsted Pedersen, Børge Grønne Nordestgaard
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD? Current atherosclerosis reports (2023)
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, Børge Grønne Nordestgaard
Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study. Diabetologia (2023)
Benjamin Nilsson Wadström, Anders Berg Wulff, Kasper Mønsted Pedersen, Børge Grønne Nordestgaard
Remnant cholesterol in the era of intensive lipid-lowering therapies. European heart journal (2023)
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, Børge Grønne Nordestgaard
Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. European heart journal (2023)
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, Børge Grønne Nordestgaard
Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. European heart journal (2023)
Benjamin Nilsson Wadström, Anders Berg Wulff, Kasper Mønsted Pedersen, Gorm Boje Jensen, Børge Grønne Nordestgaard
Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study. European heart journal (2021)
Anders Berg Wulff, Joan Lilja Sunnleyg Højgaard, Linda Hilsted
Spectrophotometry of cerebrospinal fluid for xanthochromia is a sensitive and specific test for subarachnoid bleeding but adds little to computed tomography. Scandinavian journal of clinical and laboratory investigation 80 (8) (2020)